AstraZeneca
As one of the world’s leading pharmaceutical companies, AstraZeneca is committed to making a contribution to improving health in the developing world. AstraZeneca’s approach centres on applying their skills and experience in infection research to finding a new treatment for TB, a major threat to life in the developing world, and on forging partnerships that help to strengthen local communities’ ability to fight this devastating disease.
AMREF and AstraZeneca
TB Control and Prevention in South Africa
AstraZeneca previously funded a TB control and prevention project in Sakhisizwe, Eastern Cape. The project has succeeded in improving adherence rates to TB treatment by training community health workers to support TB patients to take their drugs correctly. The project also increased community knowledge on TB and improved the nutritional status of TB patients through education and community gardening projects.
Integrating HIV, TB and malaria services in Uganda
AstraZeneca is currently funding a project in Uganda integrating HIV, TB and malaria services in Luwero and Kiboga districts in central Uganda. Click here for more information.
“We are proud to work with organisations such as AMREF with whom we share a common goal – to help vulnerable communities create the sustainable healthcare frameworks they need for the long-term management and prevention of life-threatening disease”.
Matti Ojanen - Director of International Affairs & Public Policy